Review



easysep tm human cd3 positive selection kit ii  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc easysep tm human cd3 positive selection kit ii
    Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
    Easysep Tm Human Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/easysep+human+t+cell+isolation+kit/pmc11905684-40-9-17
    Average 90 stars, based on 1 article reviews
    easysep tm human cd3 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer"

    Article Title: Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer

    Journal: Experimental Hematology & Oncology

    doi: 10.1186/s40164-025-00625-8

    Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
    Figure Legend Snippet: Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

    Techniques Used: Electroporation, Expressing, Comparison, Flow Cytometry, Immunopeptidomics, Transfection, CCK-8 Assay, CFSE Assay, Cell Counting

    Related Articles

    Isolation:

    Article Title: Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages
    Article Snippet: .. T cells were isolated from PBMCs using the EasySep TM Human CD3 positive selection kit II (STEMCELL) according to the manufacturer’s protocol. .. T cells were stained in PBS with the CellTrace TM CFSE Cell Proliferation Kit (ThermoFisher) according to the manufacturer’s protocol and suspended in RPMI1640 medium containing 10% FBS.

    Selection:

    Article Title: Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages
    Article Snippet: .. T cells were isolated from PBMCs using the EasySep TM Human CD3 positive selection kit II (STEMCELL) according to the manufacturer’s protocol. .. T cells were stained in PBS with the CellTrace TM CFSE Cell Proliferation Kit (ThermoFisher) according to the manufacturer’s protocol and suspended in RPMI1640 medium containing 10% FBS.

    other:

    Article Title: Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer
    Article Snippet: CD3 + T cells were then purified employing the EasySep Human CD3 Positive Selection Kit II (Stemcell, 17851).

    Article Title: Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcγR-Deficient Human IL-15 Transgenic Mouse
    Article Snippet: For in vivo transplantation, thawed NK cells were further purified by eliminating human CD3 + T cells (EasySep TM Human CD3 positive selection kit II, STEMCELL TM technologies, Vancouver, Canada).



    Similar Products

    easysep tm human cd3 positive selection kit ii  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep tm human cd3 positive selection kit ii
    Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
    Easysep Tm Human Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/easysep+human+t+cell+isolation+kit/pmc11905684-40-9-17
    Average 90 stars, based on 1 article reviews
    easysep tm human cd3 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    easysep tm human cd19/cd3 positive selection kit ii  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easysep tm human cd19/cd3 positive selection kit ii
    Optimization of electroporation conditions for circRNA expression in <t>Human</t> <t>CD3</t> + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester
    Easysep Tm Human Cd19/Cd3 Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/easysep+tm+human+cd3+positive+selection+kit+ii/easysep+human+t+cell+isolation+kit/pmc08909053-42-15-23
    Average 90 stars, based on 1 article reviews
    easysep tm human cd19/cd3 positive selection kit ii - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

    Journal: Experimental Hematology & Oncology

    Article Title: Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer

    doi: 10.1186/s40164-025-00625-8

    Figure Lengend Snippet: Optimization of electroporation conditions for circRNA expression in Human CD3 + T cells. A Comparison of EGFP expression in T cells electroporated with circRNA at different voltages (1400V, 1600V, and 1800V). B Flow cytometry analysis of anti-DLL3 CAR expression at varying electroporation voltages. C Evaluation of CAR expression and apoptosis rates in T cells electroporated with various concentrations of circRNA (1–6 µg/million cells). D Assessment of immunogenicity in circRNA and mRNA-transfected T cells under optimized electroporation conditions. E Assessment of CAR expression duration in circRNA and mRNA-transfected T cells. F Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CCK-8 assay. G Evaluation of cell proliferation in circRNA and mRNA-transfected T cells using the CFSE assay. circRNA circular RNA, mRNA messenger RNA, EGFP enhanced green fluorescent protein, CAR-T chimeric antigen receptor T cell, DLL3 Delta-like Ligand 3, CCK-8 Cell Counting Kit-8, CFSE Carboxyfluorescein Succinimidyl Ester

    Article Snippet: CD3 + T cells were then purified employing the EasySep TM Human CD3 Positive Selection Kit II (Stemcell, 17851).

    Techniques: Electroporation, Expressing, Comparison, Flow Cytometry, Immunopeptidomics, Transfection, CCK-8 Assay, CFSE Assay, Cell Counting